Skip to main content
Fig. 2 | BMC Women's Health

Fig. 2

From: Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women

Fig. 2

Bar graphs showing the distributions of high-risk human papillomavirus (HR-HPV) DNA test utilization (a) and receipt of at least one HR-HPV DNA positive test result (b) among women ≥29 years who sought cervical care through the New Jersey Cancer Education and Early Detection (NJCEED) Program, by New Jersey county of residence, 2009–2015. NOTE: The overall rate of HR-HPV testing among NJCEED participants was 26.6% (13,440 of the 50,510 unique patients had at least one HR-HPV DNA test) and the overall rate of having received at least on positive HR-HPV test result was 13.3% (1792 of the 13,440 patients who ever had a HR-HPV DNA test had at least one positive test result)

Back to article page